References
- Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol 2008; 8:713 - 25; http://dx.doi.org/10.1038/nri2381; PMID: 19172692
- Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29:235 - 71; http://dx.doi.org/10.1146/annurev-immunol-031210-101324; PMID: 21219185
- Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000; 356:1795 - 9; http://dx.doi.org/10.1016/S0140-6736(00)03231-1; PMID: 11117911
- Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 2012; 12:239 - 52; http://dx.doi.org/10.1038/nri3174; PMID: 22437937
- Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 2008; 9:486 - 94; http://dx.doi.org/10.1038/ni1580; PMID: 18425105
- Uherek C, Tonn T, Uherek B, Becker S, Schnierle B, Klingemann H-G, et al. Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction. Blood 2002; 100:1265 - 73; PMID: 12149207
- Sahm C, Schönfeld K, Wels WS. Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor. Cancer Immunol Immunother 2012; 61:1451 - 61; http://dx.doi.org/10.1007/s00262-012-1212-x; PMID: 22310931
- Stojanovic A, Cerwenka A. Natural killer cells and solid tumors. J Innate Immun 2011; 3:355 - 64; http://dx.doi.org/10.1159/000325465; PMID: 21502747
- Oberoi P, Jabulowsky RA, Bähr-Mahmud H, Wels WS. EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells. PLoS One 2013; 8:e61267; http://dx.doi.org/10.1371/journal.pone.0061267; PMID: 23573299
- Oberoi P, Jabulowsky RA, Wels WS. Selective induction of cancer cell death by targeted granzyme B. Antibodies 2013; 2:130 - 51; http://dx.doi.org/10.3390/antib2010130